Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
09/01/2005 | WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
09/01/2005 | WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity |
09/01/2005 | WO2005080361A1 Histamine-3 receptor modulators |
09/01/2005 | WO2005080356A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits |
09/01/2005 | WO2005080348A1 Novel sulfone amide derivative |
09/01/2005 | WO2005080334A1 Novel heterocyclic compound |
09/01/2005 | WO2005080330A1 Heteroarylphenylurea derivative |
09/01/2005 | WO2005079868A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses |
09/01/2005 | WO2005079574A1 Bicyclic melanocorin-specific compounds |
09/01/2005 | WO2005079195A2 Pyrazolopyridines and analogs thereof |
09/01/2005 | WO2005063744A3 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
09/01/2005 | WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
09/01/2005 | WO2005037271A3 Large conductance calcium-activated k channel opener |
09/01/2005 | WO2004078757A3 Synthesis of 5-substituted 7-azaindoles and 7-azaidonines |
09/01/2005 | WO2004076450A8 Pyrazolopyridine derivates |
09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
09/01/2005 | US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
09/01/2005 | US20050192333 Spirocyclic cyclohexane compounds |
09/01/2005 | US20050192320 (2-Carboxamido)(3-amino)thiophene compounds |
09/01/2005 | US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs) |
09/01/2005 | US20050192304 Rho-kinase inhibitors |
09/01/2005 | US20050192303 Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds |
09/01/2005 | US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity |
09/01/2005 | US20050192295 6-Chloro-N-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methylphenyl)pyrazolo[1,5- alpha ]pyridin-7-amine or salt; treatment of a herpes viral infection in human |
09/01/2005 | US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
09/01/2005 | US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile |
09/01/2005 | US20050191643 Cyanine compounds and their application as quenching compounds |
09/01/2005 | US20050189515 Liquid crystal compounds, preparation thereof, and composition containing the same |
09/01/2005 | DE10247680B4 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase New bicyclic inhibitors of hormone sensitive lipase |
09/01/2005 | DE102004004973A1 New 7-phenylamino-quinolone or 1,8-naphthyridone derivatives, useful e.g. for treating type II diabetes or arteriosclerosis, are inhibitors of glycogen phosphorylase |
09/01/2005 | CA2556589A1 4-substituted piperidine derivatives |
09/01/2005 | CA2556350A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1) |
09/01/2005 | CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
09/01/2005 | CA2555409A1 Novel sulfone amide derivative |
09/01/2005 | CA2555073A1 Amino heterocyclic modulators of chemokine receptor activity |
09/01/2005 | CA2555071A1 Histamine-3 receptor modulators |
09/01/2005 | CA2554774A1 Novel heterocyclic compound |
09/01/2005 | CA2540598A1 Pyrazolopyridines and analogs thereof |
08/31/2005 | EP1568699A1 1,3-dihydroimidazole fused-ring compound |
08/31/2005 | EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
08/31/2005 | EP1567517A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
08/31/2005 | EP1567501A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
08/31/2005 | EP1567497A2 Pyridines for treating injured mammalian nerve tissue |
08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives |
08/31/2005 | EP1567112A2 Novel chemical compounds |
08/31/2005 | EP1442137A4 Universal nucleotides for nucleic acid analysis |
08/31/2005 | EP1417207B1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
08/31/2005 | EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
08/31/2005 | EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
08/31/2005 | EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3 |
08/31/2005 | EP1221444B1 Fused imidazole compounds and remedies for diabetes mellitus |
08/31/2005 | EP1117297B1 Synthetic analogs of ecteinascidin-743 |
08/31/2005 | CN1662535A Spiroindolinepiperidine derivatives |
08/31/2005 | CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
08/31/2005 | CN1662533A [1, 4]diazepino[6, 7, 1-ij]quinoline derivatives as anti psychotic and antiobesity agents |
08/31/2005 | CN1662532A Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
08/31/2005 | CN1662531A Hetero-bicyclic compounds |
08/31/2005 | CN1662524A Indole derivatives useful as histamine h3 antagonists |
08/31/2005 | CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
08/31/2005 | CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
08/31/2005 | CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
08/31/2005 | CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
08/31/2005 | CN1660845A Method for preparing vindoline and Catharanthine |
08/31/2005 | CN1660844A Compound of quinacridones-carbazole group and application in organic electroluminescence device |
08/31/2005 | CN1660842A Preparation of 4-hydroxy-3-nitro-2(1h)-pyridone from 2-hydroxy-3-cyano-4-methoxypyridine |
08/31/2005 | CN1660839A Chemical compounds |
08/31/2005 | CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method |
08/31/2005 | CN1216885C Heterocycle substd. condensed heterocyclic derivs. with bioactivity |
08/31/2005 | CN1216884C Dibenz [a.g] quinolizinium derivatives and salts thereof |
08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
08/31/2005 | CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
08/30/2005 | US6936714 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
08/30/2005 | US6936631 Bicyclic imidazo-5-yl-amine derivatives |
08/30/2005 | US6936623 Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders |
08/30/2005 | US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof. |
08/30/2005 | US6936619 Quinazolinone compounds useful in therapy |
08/30/2005 | US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders |
08/30/2005 | US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
08/30/2005 | US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention |
08/30/2005 | US6936603 Treating autoimmune diseases mediated by cathepsin S |
08/30/2005 | US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
08/25/2005 | WO2005077949A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof |
08/25/2005 | WO2005077948A1 Fungicidal heterocyclic compounds |
08/25/2005 | WO2005077947A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
08/25/2005 | WO2005077946A1 Dihydrotetrabenazines and pharmaceutical compositions containing them |
08/25/2005 | WO2005077944A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
08/25/2005 | WO2005077912A1 Indazole compound and pharmaceutical use thereof |
08/25/2005 | WO2005077905A1 Fused-ring 4-oxopyrimidine derivative |
08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
08/25/2005 | WO2005077696A1 Wheel drive |
08/25/2005 | WO2005077695A1 Steering and driving system for an industrial truck |
08/25/2005 | WO2005077369A1 Piperidine derivatives useful as ccr3 antagonists |
08/25/2005 | WO2005077363A1 Heterocyclic gaba-a subtype selective receptor modulators |
08/25/2005 | WO2005077344A2 Hydantoin derivatives as inhibitors of cellular necrosis |
08/25/2005 | WO2005077050A2 Hiv integrase inhibitors |
08/25/2005 | WO2005076861A2 Compounds that inhibit hiv particle formation |
08/25/2005 | WO2005076815A2 PERYLENE n-TYPE SEMICONDUCTORS AND RELATED DEVICES |
08/25/2005 | WO2005076783A2 Sulfone substituted imidazo ring ethers |
08/25/2005 | WO2005063767A3 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
08/25/2005 | WO2005058909A3 Method of preparing porphyrin derivatives, porphyrin derivatives, uses thereof and pharmaceutical compositions |